PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Dec-2022 The global surface plasmon resonance market is expected to reach US$ 1807.7 Mn by 2032 | FMI MARKITWIRED
08-Dec-2022 Including Novel Medication in Therapies would create Expansion Opportunities for the Menopause Treatment Market: Future Market Insights MARKITWIRED
08-Dec-2022 PDC*line Pharma presents first immunological results from phase I/II trial with PDC*lung01 at ESMO-IO 2022 Andrew Lloyd Associates
08-Dec-2022 Rise in the Chronic Oral Diseases is expected to propel the Growth of the Intraoral Scanners Market 2022-2032 MARKITWIRED
08-Dec-2022 Sosei Heptares Enters R&D Agreements with the University of Oxford and KU Leuven to Identify and Validate Key GPCRs Driving Gastrointestinal and Immune Disorders Sosei Heptares
08-Dec-2022 Bloomsbury Genetic Therapies Announces CTA Filing for a Phase I/II Study for its Lead Gene Therapy Program Bloomsbury Genetic Therapies
08-Dec-2022 First AML Patient Successfully Transplanted with Vor Bio’s Investigational Trem-cel (VOR33) and Tolerated Mylotarg™ Vor Bio
08-Dec-2022 Alliance Pharma Opens State-of- the-Art Bioanalytical Laboratory in Brisbane Alliance Pharma
08-Dec-2022 Dante Genomics launches doctor ordered, clinical whole genome sequencing in the U.S. in partnership with 1health.io Dante Genomics
08-Dec-2022 SK pharmteco announces new standalone Analytical Services from its SK biotek Ireland Swords Campus SK pharmteco
08-Dec-2022 Laevoroc Oncology Announces Publication Identifying Purine Nucleoside Phosphorylase (PNP) as a Novel Metabolic Immune Checkpoint Laevoroc Oncology
08-Dec-2022 The Lancet Publishes Results from Two Bimekizumab Phase 3 Studies in Psoriatic Arthritis UCB
08-Dec-2022 MetrioPharm Announces Topline Data of its Phase IIa Study of MP1032 in COVID-19 Patients MetrioPharm AG
08-Dec-2022 Neuraxpharm expands into the Netherlands Neuraxpharm
08-Dec-2022 Anjarium Biosciences appoints ex-Novartis gene therapy leader Otmane Boussif, DSc as Chief Technology Officer Anjarium Biosciences
08-Dec-2022 BRIM Biotechnology receives FDA Orphan Drug Designation for BRM424 to treat neurotrophic keratitis Sciad Newswire
08-Dec-2022 Relief Therapeutics Announces Executive Leadership Team Changes Relief Therapeutics Holding SA
08-Dec-2022 Biotest AG: First patient enrolled in phase II clinical trial for treatment of chronic hepatitis B with hyperimmunoglobulins Biotest AG
08-Dec-2022 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Daktronics, Inc. (DAKT) on Behalf of Investors Businesswire
08-Dec-2022 Shareholder Alert: Robbins LLP Informs Investors of Class Action Against NeoGenomics, Inc. (NEO) Businesswire